These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3082044)

  • 1. Freezing of plasma and recovery of factor VIII.
    Carlebjörk G; Blombäck M; Pihlstedt P
    Transfusion; 1986; 26(2):159-62. PubMed ID: 3082044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of temperature on plasma freezing under industrial conditions.
    Bravo MI; Grancha S; Jorquera JI
    Pharmeur Sci Notes; 2006 Aug; 2006(1):31-5. PubMed ID: 17694644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for preparation of good quality cryoprecipitate.
    De M; Banerjee D; Chandra S; Bhattacharya DK
    Indian J Med Res; 1989 Feb; 90():32-5. PubMed ID: 2498203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of plasma segments for estimating factor VIII activity in pools of fresh frozen plasma.
    Ofosu FA; Smith LM; Blajchman MA; Campbell J; De Vries C; Wah P
    Vox Sang; 1987; 52(3):254-6. PubMed ID: 3111094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of factor VIII activity in plasma by different freezing techniques, as determined with a chromogenic microtray assay.
    Vaara I; Jonsson M
    Scand J Clin Lab Invest; 1989 Apr; 49(2):161-4. PubMed ID: 2520368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
    Vermeer C; Soute BA; Ates G; Brummelhuis HG
    Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII.
    Mason EC
    Lancet; 1978 Jul; 2(8079):15-7. PubMed ID: 78212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recovery of factor VIII from fresh-frozen indated and outdated human plasma.
    Whitman DE; Switzer ME; McKee PA
    Thromb Haemost; 1976 Aug; 36(1):71-7. PubMed ID: 1036829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of factor VIII recovery in cryoprecipitate.
    Kasper CK; Myhre BA; McDonald JD; Nakasako Y; Feinstein DI
    Transfusion; 1975; 15(4):312-22. PubMed ID: 1166504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.